Outset Medical is a privately held company backed by a top-tier syndicate of investors, including Fidelity, T. Rowe Price and Warburg Pincus, pioneering the use of a new dialysis medical technology ecosystem that could profoundly change the way hemodialysis treatment is delivered. Historically, patients have had to endure little choice and control over their treatments in dialysis clinics, creating one of the least consumer-friendly sectors in medicine, and making it one of the most labor-intensive and costly for the providers who sustain it. Outset is introducing a new technology aimed at disrupting both the cost structure and patient experience of dialysis within four market segments -- dialysis clinics, hospitals, extended care facilities and home.
For more information about the company, please contact firstname.lastname@example.org.
For more information about job opportunities, please contact email@example.com.